$MOH
MOLINA HEALTHCARE, INC. Stock $moh

$moh Overview Financials Valuation SEC Filings Company Website

2017 Q1 Form 10-Q Financial Statement

#000117992917000099 Filed on May 04, 2017

Income Statement

Concept	2017 Q1	2016 Q4	2016 Q1
Revenue	$4.904B	$4.534B	$4.343B
YoY Change	12.92%	17.14%	36.96%
Cost Of Revenue	$4.233B	$3.967B	$3.715B
YoY Change	13.94%	20.1%	39.05%
Gross Profit	$546.0M	$354.0M	$434.0M
YoY Change	25.81%	-37.63%	23.65%
Gross Profit Margin	11.13%	7.81%	9.99%
Selling, General & Admin	$550.0M	$536.0M	$507.0M
YoY Change	8.48%	15.69%	29.27%
% of Gross Profit	100.73%	151.41%	116.82%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$49.00M	$47.00M	$44.00M
YoY Change	11.36%	40.72%	33.33%
% of Gross Profit	8.97%	13.28%	10.14%
Operating Expenses	$589.0M	$573.0M	$539.0M
YoY Change	9.28%	16.63%	29.19%
Operating Profit	$82.00M	-$6.000M	$89.00M
YoY Change	-7.87%	-107.89%	8.54%
Interest Expense	$26.00M	-$25.00M	$25.00M
YoY Change	4.0%	19.62%	66.67%
% of Operating Profit	31.71%		28.09%
Other Income/Expense, Net	$49.00M		-$25.00M
YoY Change	-296.0%		66.67%
Pretax Income	$131.0M	-$31.00M	$64.00M
YoY Change	104.69%	-155.06%	-4.48%
Income Tax	$54.00M	$16.00M	$40.00M
% Of Pretax Income	41.22%		62.5%
Net Earnings	$77.00M	-$47.00M	$24.00M
YoY Change	220.83%	-256.67%	-14.29%
Net Earnings / Revenue	1.57%	-1.04%	0.55%
Basic Earnings Per Share	$1.38	-$0.85	$0.44
Diluted Earnings Per Share	$1.37	-$0.85	$0.43
COMMON SHARES
Basic Shares Outstanding	56.00M shares	56.82M shares	55.00M shares
Diluted Shares Outstanding	56.00M shares		57.00M shares

Balance Sheet

Concept	2017 Q1	2016 Q4	2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.254B	$4.577B	$4.226B
YoY Change	24.33%	10.82%	37.48%
Cash & Equivalents	$3.198B	$2.819B	$2.156B
Short-Term Investments	$2.056B	$1.758B	$2.070B
Other Short-Term Assets	$142.0M	$398.0M	$637.0M
YoY Change	-77.71%	-29.68%	229.2%
Inventory
Prepaid Expenses
Receivables	$1.006B	$974.0M	$863.0M
Other Receivables	$0.00	$39.00M	$38.00M
Total Short-Term Assets	$6.402B	$5.988B	$5.764B
YoY Change	11.07%	12.85%	34.81%
LONG-TERM ASSETS
Property, Plant & Equipment	$447.0M	$454.0M	$419.0M
YoY Change	6.68%	15.52%	21.55%
Goodwill	$620.0M	$620.0M	$619.0M
YoY Change	0.16%	19.46%	127.54%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$43.00M	$41.00M	$37.00M
YoY Change	16.22%	46.43%	8.62%
Total Long-Term Assets	$1.636B	$1.461B	$1.419B
YoY Change	15.29%	15.04%	58.69%
TOTAL ASSETS
Total Short-Term Assets	$6.402B	$5.988B	$5.764B
Total Long-Term Assets	$1.636B	$1.461B	$1.419B
Total Assets	$8.038B	$7.449B	$7.183B
YoY Change	11.9%	13.28%	38.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$438.0M	$385.0M	$601.0M
YoY Change	-27.12%	6.35%	40.55%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.000M	$472.0M	$455.0M
YoY Change	-99.78%	5.12%	3.26%
Total Short-Term Liabilities	$4.422B	$4.570B	$4.377B
YoY Change	1.03%	19.57%	21.81%
LONG-TERM LIABILITIES
Long-Term Debt	$1.653B	$975.0M	$1.163B
YoY Change	42.13%	-15.95%	146.4%
Other Long-Term Liabilities	$44.00M	$42.00M	$38.00M
YoY Change	15.79%	13.51%	13.95%
Total Long-Term Liabilities	$1.697B	$1.017B	$38.00M
YoY Change	4365.79%	-15.04%	13.95%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.422B	$4.570B	$4.377B
Total Long-Term Liabilities	$1.697B	$1.017B	$38.00M
Total Liabilities	$6.311B	$5.800B	$5.593B
YoY Change	12.84%	15.56%	35.5%
SHAREHOLDERS EQUITY
Retained Earnings	$887.0M	$810.0M	$782.0M
YoY Change	13.43%	6.86%	21.52%
Common Stock	$841.0M	$841.0M	$806.0M
YoY Change	4.34%	4.73%	102.44%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.727B	$1.649B	$1.590B
YoY Change
Total Liabilities & Shareholders Equity	$8.038B	$7.449B	$7.183B
YoY Change	11.9%	13.28%	38.94%

Cashflow Statement

Concept	2017 Q1	2016 Q4	2016 Q1
OPERATING ACTIVITIES
Net Income	$77.00M	-$47.00M	$24.00M
YoY Change	220.83%	-256.67%	-14.29%
Depreciation, Depletion And Amortization	$49.00M	$47.00M	$44.00M
YoY Change	11.36%	40.72%	33.33%
Cash From Operating Activities	$719.0M	$40.00M	$139.0M
YoY Change	417.27%	-81.75%	-74.91%
INVESTING ACTIVITIES
Capital Expenditures	$26.00M	-$33.00M	$46.00M
YoY Change	-43.48%	4.43%	-284.0%
Acquisitions	$0.00		$2.000M
YoY Change	-100.0%		-75.0%
Other Investing Activities	$6.000M	-$42.00M	-$1.000M
YoY Change	-700.0%	-94.19%	-114.29%
Cash From Investing Activities	-$337.0M	-$75.00M	-$314.0M
YoY Change	7.32%	-90.06%	37.72%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$1.000M	8.000M	$2.000M
YoY Change	-150.0%	-98.86%	-60.0%
NET CHANGE
Cash From Operating Activities	$719.0M	40.00M	$139.0M
Cash From Investing Activities	-$337.0M	-75.00M	-$314.0M
Cash From Financing Activities	-$1.000M	8.000M	$2.000M
Net Change In Cash	$381.0M	-27.00M	-$173.0M
YoY Change	-320.23%	-116.37%	-152.27%
FREE CASH FLOW
Cash From Operating Activities	$719.0M	$40.00M	$139.0M
Capital Expenditures	$26.00M	-$33.00M	$46.00M
Free Cash Flow	$693.0M	$73.00M	$93.00M
YoY Change	645.16%	-70.89%	-83.94%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017Q1	dei	Amendment Flag AmendmentFlag	false
CY2017Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2017Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2017Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
CY2017Q1	dei	Document Period End Date DocumentPeriodEndDate	2017-03-31
CY2017Q1	dei	Document Type DocumentType	10-Q
CY2017Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001179929
CY2017Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	57004000	shares
CY2017Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2017Q1	dei	Entity Registrant Name EntityRegistrantName	MOLINA HEALTHCARE INC
CY2017Q1	dei	Trading Symbol TradingSymbol	moh
CY2016Q4	moh	Affordable Care Act Premium Stabilization Program Minimum Medical Loss Ratio Receivable Payable AffordableCareActPremiumStabilizationProgramMinimumMedicalLossRatioReceivablePayable	-1000000	USD
CY2017Q1	moh	Affordable Care Act Premium Stabilization Program Minimum Medical Loss Ratio Receivable Payable AffordableCareActPremiumStabilizationProgramMinimumMedicalLossRatioReceivablePayable	-40000000	USD
CY2017Q1	moh	Affordable Care Act Premium Stabilization Program Minimum Medical Loss Ratio Receivable Payable Current Year AffordableCareActPremiumStabilizationProgramMinimumMedicalLossRatioReceivablePayableCurrentYear	-37000000	USD
CY2017Q1	moh	Affordable Care Act Premium Stabilization Program Minimum Medical Loss Ratio Receivable Payable Prior Years AffordableCareActPremiumStabilizationProgramMinimumMedicalLossRatioReceivablePayablePriorYears	-3000000	USD
CY2016Q4	moh	Affordable Care Act Premium Stabilization Program Reinsurance Receivable Payable AffordableCareActPremiumStabilizationProgramReinsuranceReceivablePayable	55000000	USD
CY2017Q1	moh	Affordable Care Act Premium Stabilization Program Reinsurance Receivable Payable AffordableCareActPremiumStabilizationProgramReinsuranceReceivablePayable	58000000	USD
CY2017Q1	moh	Affordable Care Act Premium Stabilization Program Reinsurance Receivable Payable Current Year AffordableCareActPremiumStabilizationProgramReinsuranceReceivablePayableCurrentYear	0	USD
CY2017Q1	moh	Affordable Care Act Premium Stabilization Program Reinsurance Receivable Payable Prior Years AffordableCareActPremiumStabilizationProgramReinsuranceReceivablePayablePriorYears	58000000	USD
CY2016Q4	moh	Affordable Care Act Premium Stabilization Program Risk Adjustment Receivable Payable AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivablePayable	-522000000	USD
CY2017Q1	moh	Affordable Care Act Premium Stabilization Program Risk Adjustment Receivable Payable AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivablePayable	-769000000	USD
CY2017Q1	moh	Affordable Care Act Premium Stabilization Program Risk Adjustment Receivable Payable Current Year AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivablePayableCurrentYear	-247000000	USD
CY2017Q1	moh	Affordable Care Act Premium Stabilization Program Risk Adjustment Receivable Payable Prior Years AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivablePayablePriorYears	-522000000	USD
CY2017Q1	moh	Affordable Care Act Premium Stabilization Program Risk Corridor Receivable Not Recognized Current Year AffordableCareActPremiumStabilizationProgramRiskCorridorReceivableNotRecognizedCurrentYear	90000000	USD
CY2017Q1	moh	Affordable Care Act Premium Stabilization Program Risk Corridor Receivable Not Recognized Prior Years AffordableCareActPremiumStabilizationProgramRiskCorridorReceivableNotRecognizedPriorYears	52000000	USD
CY2016Q4	moh	Affordable Care Act Premium Stabilization Program Risk Corridor Receivable Payable AffordableCareActPremiumStabilizationProgramRiskCorridorReceivablePayable	-1000000	USD
CY2017Q1	moh	Affordable Care Act Premium Stabilization Program Risk Corridor Receivable Payable AffordableCareActPremiumStabilizationProgramRiskCorridorReceivablePayable	-5000000	USD
CY2017Q1	moh	Affordable Care Act Premium Stabilization Program Risk Corridor Receivable Payable Current Year AffordableCareActPremiumStabilizationProgramRiskCorridorReceivablePayableCurrentYear	0	USD
CY2017Q1	moh	Affordable Care Act Premium Stabilization Program Risk Corridor Receivable Payable Prior Years AffordableCareActPremiumStabilizationProgramRiskCorridorReceivablePayablePriorYears	-5000000	USD
CY2016Q1	moh	Amortizationof Debt Discount Premiumand Sale Leaseback Financing Obligation AmortizationofDebtDiscountPremiumandSaleLeasebackFinancingObligation	8000000	USD
CY2017Q1	moh	Amortizationof Debt Discount Premiumand Sale Leaseback Financing Obligation AmortizationofDebtDiscountPremiumandSaleLeasebackFinancingObligation	8000000	USD
CY2016Q1	moh	Business Combination Prepaid Consideration Transferred BusinessCombinationPrepaidConsiderationTransferred	102000000	USD
CY2017Q1	moh	Business Combination Prepaid Consideration Transferred BusinessCombinationPrepaidConsiderationTransferred	0	USD
CY2016Q1	moh	Business Combination Purchase Price Amounts Accrued Received BusinessCombinationPurchasePriceAmountsAccruedReceived	30000000	USD
CY2017Q1	moh	Business Combination Purchase Price Amounts Accrued Received BusinessCombinationPurchasePriceAmountsAccruedReceived	0	USD
CY2016Q4	moh	Capitation Claims Payable CapitationClaimsPayable	37000000	USD
CY2017Q1	moh	Capitation Claims Payable CapitationClaimsPayable	36000000	USD
CY2016Q1	moh	Changes In Amounts Due To And Due From Affiliates ChangesInAmountsDueToAndDueFromAffiliates	0	USD
CY2017Q1	moh	Changes In Amounts Due To And Due From Affiliates ChangesInAmountsDueToAndDueFromAffiliates	0	USD
CY2017Q1	moh	Classof Warrantor Right Stated Percentage ClassofWarrantorRightStatedPercentage	0.01125
CY2016Q1	moh	Health Care Organization Insurer Fee Expense HealthCareOrganizationInsurerFeeExpense	58000000	USD
CY2017Q1	moh	Health Care Organization Insurer Fee Expense HealthCareOrganizationInsurerFeeExpense	0	USD
CY2016Q1	moh	Health Care Organization Insurer Fee Revenue HealthCareOrganizationInsurerFeeRevenue	90000000	USD
CY2017Q1	moh	Health Care Organization Insurer Fee Revenue HealthCareOrganizationInsurerFeeRevenue	0	USD
CY2016Q1	moh	Health Care Organization Premium Tax Revenue HealthCareOrganizationPremiumTaxRevenue	109000000	USD
CY2017Q1	moh	Health Care Organization Premium Tax Revenue HealthCareOrganizationPremiumTaxRevenue	111000000	USD
CY2016Q4	moh	Health Care Reform Premium Deficiency Reserve HealthCareReformPremiumDeficiencyReserve	30000000	USD
CY2017Q1	moh	Health Care Reform Premium Deficiency Reserve HealthCareReformPremiumDeficiencyReserve	22000000	USD
CY2016Q1	moh	Increase Decrease In Medical Premium Liability Due To Agency IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency	181000000	USD
CY2017Q1	moh	Increase Decrease In Medical Premium Liability Due To Agency IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency	373000000	USD
CY2016Q4	moh	Medical Claims And Benefits Payable MedicalClaimsAndBenefitsPayable	225000000	USD
CY2017Q1	moh	Medical Claims And Benefits Payable MedicalClaimsAndBenefitsPayable	131000000	USD
CY2016Q1	moh	Medical Claims And Benefits Payable Adjustments Change In Provider MedicalClaimsAndBenefitsPayableAdjustmentsChangeInProvider	24000000	USD
CY2017Q1	moh	Medical Claims And Benefits Payable Adjustments Change In Provider MedicalClaimsAndBenefitsPayableAdjustmentsChangeInProvider	-96000000	USD
CY2016Q4	moh	Medical Premium Liability Due To Agency MedicalPremiumLiabilityDueToAgency	1202000000	USD
CY2017Q1	moh	Medical Premium Liability Due To Agency MedicalPremiumLiabilityDueToAgency	1575000000	USD
CY2016Q1	moh	Net Income Loss From Continuing Operations Before Equity Method Investments Extraordinary Items Noncontrolling Interest NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest	24000000	USD
CY2017Q1	moh	Net Income Loss From Continuing Operations Before Equity Method Investments Extraordinary Items Noncontrolling Interest NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest	77000000	USD
CY2017Q1	moh	Number Of Members Added NumberOfMembersAdded	500000	member
CY2016Q4	moh	Other Claims Payable OtherClaimsPayable	428000000	USD
CY2017Q1	moh	Other Claims Payable OtherClaimsPayable	332000000	USD
CY2016Q4	moh	Pharmacy Claims Payable PharmacyClaimsPayable	112000000	USD
CY2017Q1	moh	Pharmacy Claims Payable PharmacyClaimsPayable	133000000	USD
CY2016Q1	moh	Policy Holder Benefits Prior Percentage PolicyHolderBenefitsPriorPercentage	0.100
CY2017Q1	moh	Policy Holder Benefits Prior Percentage PolicyHolderBenefitsPriorPercentage	0.074
CY2016Q1	moh	Policy Holder Medical Care Cost Prior Year Percentage PolicyHolderMedicalCareCostPriorYearPercentage	0.013
CY2017Q1	moh	Policy Holder Medical Care Cost Prior Year Percentage PolicyHolderMedicalCareCostPriorYearPercentage	0.009
CY2016Q1	moh	Policy Holder Premium Revenue Prior Year Percentage PolicyHolderPremiumRevenuePriorYearPercentage	0.012
CY2017Q1	moh	Policy Holder Premium Revenue Prior Year Percentage PolicyHolderPremiumRevenuePriorYearPercentage	0.008
CY2016Q1	moh	Premium Tax Expenses PremiumTaxExpenses	109000000	USD
CY2017Q1	moh	Premium Tax Expenses PremiumTaxExpenses	111000000	USD
CY2016Q1	moh	Quality Incentive Premium Revenue As A Percentage Of Total Revenue QualityIncentivePremiumRevenueAsAPercentageOfTotalRevenue	0.006
CY2017Q1	moh	Quality Incentive Premium Revenue As A Percentage Of Total Revenue QualityIncentivePremiumRevenueAsAPercentageOfTotalRevenue	0.005
CY2017Q1	moh	Unrecognized Compensation Forfeited Rate UnrecognizedCompensationForfeitedRate	0.038
CY2016Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	385000000	USD
CY2017Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	438000000	USD
CY2016Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	0	USD
CY2017Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	21000000	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2000000	USD
CY2017Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1000000	USD
CY2016Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	841000000	USD
CY2017Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	841000000	USD
CY2016Q1	us-gaap	Administrative Services Revenue AdministrativeServicesRevenue	14000000	USD
CY2017Q1	us-gaap	Administrative Services Revenue AdministrativeServicesRevenue	13000000	USD
CY2016Q4	us-gaap	Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries	1492000000	USD
CY2017Q1	us-gaap	Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries	1527000000	USD
CY2016Q4	us-gaap	Assets Assets	7449000000	USD
CY2017Q1	us-gaap	Assets Assets	8038000000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	5988000000	USD
CY2017Q1	us-gaap	Assets Current AssetsCurrent	6402000000	USD
CY2016Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	1761000000	USD
CY2017Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	2059000000	USD
CY2016Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	1758000000	USD
CY2017Q1	us-gaap	Available For Sale Securities AvailableForSaleSecurities	2056000000	USD
CY2016Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1000000	USD
CY2017Q1	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1000000	USD
CY2016Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	4000000	USD
CY2017Q1	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	4000000	USD
CY2016Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	0	USD
CY2017Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	0	USD
CY2016Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	4000000	USD
CY2017Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	4000000	USD
CY2016Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	841000000	USD
CY2017Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	854000000	USD
CY2016Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	0	USD
CY2017Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	0	USD
CY2017Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	36000000	USD
CY2017Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	35000000	USD
CY2017Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	872000000	USD
CY2017Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	870000000	USD
CY2017Q1	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate	2056000000	USD
CY2017Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	1151000000	USD
CY2017Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	1151000000	USD
CY2016Q4	us-gaap	Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Less Than One Year AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear	580	Security
CY2017Q1	us-gaap	Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Less Than One Year AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear	525	Security
CY2016Q4	us-gaap	Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Greater Than Or Equal To One Year AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear	0	Security
CY2017Q1	us-gaap	Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Greater Than Or Equal To One Year AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear	0	Security
CY2016Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	198000000	USD
CY2017Q1	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	198000000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2329000000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2156000000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3198000000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-173000000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	379000000	USD
CY2013Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	53.8475
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2017Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2017Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2819000000	USD
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	57000000	shares
CY2017Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	57000000	shares
CY2016Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	0	USD
CY2017Q1	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	0	USD
CY2016Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	30000000	USD
CY2017Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	78000000	USD
CY2016Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	975000000	USD
CY2017Q1	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	1455000000	USD
CY2016Q1	us-gaap	Costs And Expenses CostsAndExpenses	4254000000	USD
CY2017Q1	us-gaap	Costs And Expenses CostsAndExpenses	4822000000	USD
CY2016Q4	us-gaap	Costs In Excess Of Billings On Uncompleted Contracts Or Programs Expected To Be Collected After One Year CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedAfterOneYear	86000000	USD
CY2017Q1	us-gaap	Costs In Excess Of Billings On Uncompleted Contracts Or Programs Expected To Be Collected After One Year CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedAfterOneYear	89000000	USD
CY2013	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	13490236	shares
CY2016Q4	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	6000000	USD
CY2017Q1	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	0	USD
CY2016Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	11000000	USD
CY2017Q1	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	16000000	USD
CY2016Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	315000000	USD
CY2017Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	461000000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	10000000	USD
CY2017Q1	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	10000000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	15000000	USD
CY2017Q1	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	11000000	USD
CY2016Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	32000000	USD
CY2017Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	39000000	USD
CY2016Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	44000000	USD
CY2017Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	49000000	USD
CY2016Q4	us-gaap	Derivative Assets Current DerivativeAssetsCurrent	267000000	USD
CY2017Q1	us-gaap	Derivative Assets Current DerivativeAssetsCurrent	0	USD
CY2016Q4	us-gaap	Derivative Assets Noncurrent DerivativeAssetsNoncurrent	0	USD
CY2017Q1	us-gaap	Derivative Assets Noncurrent DerivativeAssetsNoncurrent	181000000	USD
CY2016Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	0	USD
CY2017Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	0	USD
CY2016Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	267000000	USD
CY2017Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	0	USD
CY2016Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.44
CY2017Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.38
CY2016Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.43
CY2017Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.37
CY2016Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	0	USD
CY2017Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	181000000	USD
CY2017Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	39000000	USD
CY2017Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y5M
CY2016Q1	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	134000000	USD
CY2017Q1	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	0	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	140000000	USD
CY2017Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	131000000	USD
CY2016Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	340000000	USD
CY2017Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	439000000	USD
CY2016Q4	us-gaap	Goodwill Goodwill	620000000	USD
CY2017Q1	us-gaap	Goodwill Goodwill	620000000	USD
CY2016Q1	us-gaap	Gross Profit GrossProfit	420000000	USD
CY2017Q1	us-gaap	Gross Profit GrossProfit	546000000	USD
CY2016Q1	us-gaap	Health Care Organization Premium Revenue HealthCareOrganizationPremiumRevenue	3995000000	USD
CY2017Q1	us-gaap	Health Care Organization Premium Revenue HealthCareOrganizationPremiumRevenue	4648000000	USD
CY2017Q1	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	115000000	USD
CY2017Q1	us-gaap	Held To Maturity Securities Debt Maturities After One Through Five Years Fair Value HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	18000000	USD
CY2017Q1	us-gaap	Held To Maturity Securities Debt Maturities After One Through Five Years Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount	18000000	USD
CY2017Q1	us-gaap	Held To Maturity Securities Debt Maturities Within One Year Fair Value HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue	97000000	USD
CY2017Q1	us-gaap	Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount	97000000	USD
CY2017Q1	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	115000000	USD
CY2016Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	64000000	USD
CY2017Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	131000000	USD
CY2016Q1	us-gaap	Income Loss From Subsidiaries Net Of Tax IncomeLossFromSubsidiariesNetOfTax	0	USD
CY2017Q1	us-gaap	Income Loss From Subsidiaries Net Of Tax IncomeLossFromSubsidiariesNetOfTax	0	USD
CY2016Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	40000000	USD
CY2017Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	54000000	USD
CY2016Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	39000000	USD
CY2017Q1	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	0	USD
CY2016Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	205000000	USD
CY2017Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	50000000	USD
CY2016Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-24000000	USD
CY2017Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	59000000	USD
CY2016Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-30000000	USD
CY2017Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	5000000	USD
CY2016Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-129000000	USD
CY2017Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	146000000	USD
CY2016Q1	us-gaap	Increase Decrease In Health Care Insurance Liabilities IncreaseDecreaseInHealthCareInsuranceLiabilities	255000000	USD
CY2017Q1	us-gaap	Increase Decrease In Health Care Insurance Liabilities IncreaseDecreaseInHealthCareInsuranceLiabilities	-3000000	USD
CY2017Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	14000000	USD
CY2016Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	202000000	USD
CY2017Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	12000000	USD
CY2016Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	266000000	USD
CY2017Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	32000000	USD
CY2016Q1	us-gaap	Increase Decrease Of Restricted Investments IncreaseDecreaseOfRestrictedInvestments	4000000	USD
CY2017Q1	us-gaap	Increase Decrease Of Restricted Investments IncreaseDecreaseOfRestrictedInvestments	7000000	USD
CY2016Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	1000000	shares
CY2017Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2016Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1000000	shares
CY2017Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2016Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	760000000	USD
CY2017Q1	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	751000000	USD
CY2016Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	9000000	USD
CY2016Q1	us-gaap	Interest Expense InterestExpense	25000000	USD
CY2017Q1	us-gaap	Interest Expense InterestExpense	26000000	USD
CY2016Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	0	USD
CY2017Q1	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	0	USD
CY2016Q4	us-gaap	Liabilities Liabilities	5800000000	USD
CY2017Q1	us-gaap	Liabilities Liabilities	6311000000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7449000000	USD
CY2017Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8038000000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4570000000	USD
CY2017Q1	us-gaap	Liabilities Current LiabilitiesCurrent	4422000000	USD
CY2015Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	1685000000	USD
CY2016Q1	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	1940000000	USD
CY2016Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	1929000000	USD
CY2017Q1	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	1926000000	USD
CY2016Q1	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1	2241000000	USD
CY2017Q1	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1	2683000000	USD
CY2016Q1	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1	1116000000	USD
CY2017Q1	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1	1335000000	USD
CY2016Q4	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred But Not Reported Ibnr Claims Amount LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount	1352000000	USD
CY2017Q1	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred But Not Reported Ibnr Claims Amount LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount	1425000000	USD
CY2016Q1	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1	3588000000	USD
CY2017Q1	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1	4111000000	USD
CY2016Q4	us-gaap	Long Term Debt LongTermDebt	1645000000	USD
CY2017Q1	us-gaap	Long Term Debt LongTermDebt	1654000000	USD
CY2016Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	472000000	USD
CY2017Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	1000000	USD
CY2016Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1173000000	USD
CY2017Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1653000000	USD
CY2016Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	1758000000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	1000000	USD
CY2016Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	3000000	USD
CY2017Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	2056000000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2000000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1000000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-314000000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-339000000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	139000000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	719000000	USD
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	24000000	USD
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	77000000	USD
CY2016Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-25000000	USD
CY2017Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	49000000	USD
CY2017Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	Segment
CY2016Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	89000000	USD
CY2017Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	82000000	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	41000000	USD
CY2017Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	43000000	USD
CY2016Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	6000000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1000000	USD
CY2016Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	9000000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	0	USD
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	42000000	USD
CY2017Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	44000000	USD
CY2016Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	USD
CY2017Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	75000000	USD
CY2016Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	6000000	USD
CY2017Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	3000000	USD
CY2016Q1	us-gaap	Payments For Losses And Loss Adjustment Expense PaymentsForLossesAndLossAdjustmentExpense	3357000000	USD
CY2017Q1	us-gaap	Payments For Losses And Loss Adjustment Expense PaymentsForLossesAndLossAdjustmentExpense	4018000000	USD
CY2016Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-1000000	USD
CY2017Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	6000000	USD
CY2016Q1	us-gaap	Payments To Acquire Additional Interest In Subsidiaries PaymentsToAcquireAdditionalInterestInSubsidiaries	0	USD
CY2017Q1	us-gaap	Payments To Acquire Additional Interest In Subsidiaries PaymentsToAcquireAdditionalInterestInSubsidiaries	0	USD
CY2016Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	2000000	USD
CY2017Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2016Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	611000000	USD
CY2017Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	733000000	USD
CY2016Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	46000000	USD
CY2017Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	26000000	USD
CY2016Q1	us-gaap	Policyholder Benefits And Claims Incurred Health Care PolicyholderBenefitsAndClaimsIncurredHealthCare	3588000000	USD
CY2017Q1	us-gaap	Policyholder Benefits And Claims Incurred Health Care PolicyholderBenefitsAndClaimsIncurredHealthCare	4111000000	USD
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2017Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2017Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	131000000	USD
CY2017Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	142000000	USD
CY2017Q1	us-gaap	Proceeds From Dividends Received ProceedsFromDividendsReceived	0	USD
CY2016Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	0	USD
CY2017Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	1000000	USD
CY2016Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	2000000	USD
CY2017Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-2000000	USD
CY2016Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	348000000	USD
CY2017Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	433000000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	454000000	USD
CY2017Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	447000000	USD
CY2016Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	974000000	USD
CY2017Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	1006000000	USD
CY2016Q4	us-gaap	Reinsurance Recoverable For Unpaid Claims And Claims Adjustments ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments	61000000	USD
CY2017Q1	us-gaap	Reinsurance Recoverable For Unpaid Claims And Claims Adjustments ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments	67000000	USD
CY2016Q4	us-gaap	Related Party Transaction Due From To Related Party Current RelatedPartyTransactionDueFromToRelatedPartyCurrent	0	USD
CY2017Q1	us-gaap	Related Party Transaction Due From To Related Party Current RelatedPartyTransactionDueFromToRelatedPartyCurrent	0	USD
CY2016Q4	us-gaap	Restricted Investments Noncurrent RestrictedInvestmentsNoncurrent	110000000	USD
CY2017Q1	us-gaap	Restricted Investments Noncurrent RestrictedInvestmentsNoncurrent	115000000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	810000000	USD
CY2017Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	887000000	USD
CY2016Q1	us-gaap	Revenues Revenues	4343000000	USD
CY2017Q1	us-gaap	Revenues Revenues	4904000000	USD
CY2016Q1	us-gaap	Share Based Compensation ShareBasedCompensation	7000000	USD
CY2017Q1	us-gaap	Share Based Compensation ShareBasedCompensation	6000000	USD
CY2017Q1	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Balance StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance	1722000000	USD
CY2017Q1	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Required StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired	1100000000	USD
CY2016Q1	us-gaap	Stock Issued1 StockIssued1	7000000	USD
CY2017Q1	us-gaap	Stock Issued1 StockIssued1	6000000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	1649000000	USD
CY2017Q1	us-gaap	Stockholders Equity StockholdersEquity	1727000000	USD
CY2017Q1	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	-78000000	USD
CY2016Q1	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense	3755000000	USD
CY2017Q1	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense	4253000000	USD
CY2016Q1	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense	-167000000	USD
CY2017Q1	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense	-142000000	USD
CY2016Q1	us-gaap	Technology Services Costs TechnologyServicesCosts	127000000	USD
CY2017Q1	us-gaap	Technology Services Costs TechnologyServicesCosts	122000000	USD
CY2016Q1	us-gaap	Technology Services Revenue TechnologyServicesRevenue	140000000	USD
CY2017Q1	us-gaap	Technology Services Revenue TechnologyServicesRevenue	131000000	USD
CY2016Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	57000000	shares
CY2017Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	56000000	shares
CY2016Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	55000000	shares
CY2017Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	56000000	shares
CY2017Q1	us-gaap	Schedule Of Liability For Unpaid Claims And Claims Adjustment Expense ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following table provides the details of our medical claims and benefits payable (including amounts payable for the provision of long-term services and supports, or LTSS) as of the dates indicated.</font></div><div style="line-height:120%;padding-top:8px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">March 31, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">December 31,<br clear="none"/>2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">(In millions)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Fee-for-service claims incurred but not paid (IBNP)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,425</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,352</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Pharmacy payable</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">133</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">112</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Capitation payable</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">36</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">37</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">332</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">428</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,926</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,929</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

Files In Submission

Name	View Source	Status
0001179929-17-000099-index-headers.html	Edgar Link	pending
0001179929-17-000099-index.html	Edgar Link	pending
0001179929-17-000099.txt	Edgar Link	pending
0001179929-17-000099-xbrl.zip	Edgar Link	pending
a3312017-10qex311.htm	Edgar Link	pending
a3312017-10qex321.htm	Edgar Link	pending
exhibit101-changeinctrlsev.htm	Edgar Link	pending
exhibit102-2011equityincen.htm	Edgar Link	pending
exhibit103-2011equityincen.htm	Edgar Link	pending
exhibit104-2011equityincen.htm	Edgar Link	pending
exhibit105-2011equityincen.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
moh-20170331.xml	Edgar Link	completed
moh-20170331.xsd	Edgar Link	pending
moh-20170331_cal.xml	Edgar Link	unprocessable
moh-20170331_def.xml	Edgar Link	unprocessable
moh-20170331_lab.xml	Edgar Link	unprocessable
moh-20170331_pre.xml	Edgar Link	unprocessable
moh-3312017x10q.htm	Edgar Link	pending
moh-33120_chartx55244.jpg	Edgar Link	pending
molinalogo2016a13.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MOH
MOLINA HEALTHCARE, INC. Stock $moh

2017 Q1 Form 10-Q Financial Statement

#000117992917000099 Filed on May 04, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MOH MOLINA HEALTHCARE, INC. Stock $moh

2017 Q1 Form 10-Q Financial Statement

#000117992917000099 Filed on May 04, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MOH
MOLINA HEALTHCARE, INC. Stock $moh